The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation
Open accessAbstract
Interpreting the results of plasma human immunodeficiency virus type 1 (HIV-1) genotypic drug-resistance tests is one of the most difficult tasks facing clinicians caring for HIV-1-infected patients. There are many drug-resistance mutations, and they arise in complex patterns that cause varying levels of drug resistance. In addition, HIV-1 exists in vivo as a virus population containing many genomic variants. Genotypic-resistance testing detects the drug-resistance mutations present in the most common plasma virus variants but may not detect drug-resistance mutations present in minor virus variants. Therefore, interpretation systems are necessary to determine the phenotypic and clinical significance of drug-resistance mutations found in a patient's plasma virus population. We describe the scientific principles of HIV-1 genotypic-resistance test interpretation and the most commonly used Web-based resources for clinicians ordering genotypic drug-resistance tests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1
&NA; (2001) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200106000-00020 · Cited by 1,660
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database
Shafer, R. W., Stevenson, D., & Chan, B. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.348 · Cited by 907
Self-citationHuman immunodeficiency virus reverse transcriptase and protease sequence database
Rhee, S.-Y. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg100 · Cited by 817
Kuiken, C., Foley, B., Freed, E., Hahn, B., Marx, P., McCutchan, F., Mellors, J., Wolinsky, S., & Korber, B. (2002) · doi:10.2172/1184349 · Cited by 570
Hirsch, M. S., Brun‐Vezinet, F., Clotet, B., Conway, B., Kuritzkes, D. R., D’Aquila, R. T., Demeter, L. M., Hammer, S. M., Johnson, V. A., Loveday, C., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375597 · Cited by 514
Mutations in Retroviral Genes Associated with Drug Resistance
Mellors, J. W., Schinazi, R. F., & Larder, B. A. (1996) · Cited by 291
Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency Virus
Lawrence, J., Mayers, D. L., Hullsiek, K. H., Collins, G., Abrams, D. I., Reisler, R. B., Crane, L. R., Schmetter, B. S., Dionne, T. J., Saldanha, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035103 · Cited by 268
Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes
Beerenwinkel, N. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg575 · Cited by 266
2025 update of the drug resistance mutations in HIV-1.
Johnson, V. A., Brun‐Vézinet, F., Clotet, B., Conway, B., Kuritzkes, D. R., Pillay, D., Schapiro, J., Telenti, A., & Richman, D. D. (2005) · PubMed · Cited by 213
Hué, S., Clewley, J. P., Cane, P. A., & Pillay, D. (2004) · AIDS · doi:10.1097/00002030-200403260-00002 · Cited by 206
Deeks, S. G., Hoh, R., Neilands, T. B., Liegler, T. J., Aweeka, F. T., Petropoulos, C. J., Grant, R. M., & Martin, J. N. (2005) · The Journal of Infectious Diseases · doi:10.1086/496892 · Cited by 151
Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing
Vandamme, A.-M., Sönnerborg, A. B., Ait‐Khaled, M., Albert, J., Asjo, B., Bacheler, L. T., Bánhegyi, D., Boucher, C. A., Brun‐Vézinet, F., Camacho, R. J., et al. (2004) · Antiviral Therapy · doi:10.1177/135965350400900619 · Cited by 143
Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management
Allison, G., Bostrom, M. P., & Glesby, M. J. (2003) · AIDS · doi:10.1097/01.aids.0000042940.55529.93 · Cited by 127
Antiviral Activity of Lamivudine in Salvage Therapy for Multidrug‐Resistant HIV‐1 Infection
Campbell, T., Shulman, N. S., Johnson, S. C., Zolopa, A. R., Young, R. K., Bushman, L. R., Fletcher, C. V., Lanier, E. R., Merigan, T. C., & Kuritzkes, D. R. (2005) · Clinical Infectious Diseases · doi:10.1086/430709 · Cited by 124
Computational methods for the design of effective therapies against drug resistant HIV strains
Beerenwinkel, N., Sing, T., Lengauer, T., Rahnenführer, J., Roomp, K., Savenkov, I., Fischer, R., Hoffmann, D. E., Selbig, J., Korn, K., et al. (2005) · Computer applications in the biosciences · doi:10.1093/bioinformatics/bti654 · Cited by 105
Marcelin, A., Lamotte, C., Delaugerre, C., Ktorza, N., Aït-Mohand, H., Cacace, R., Bonmarchand, M., Wirden, M., Simon, A., Bossi, P., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.594-600.2003 · Cited by 98
Vora, S., Marcelin, A., Günthard, H. F., Flandre, P., Hirsch, H. H., Masquelier, B., Zinkernagel, A. S., Peytavin, G., Cálvez, V., Perrin, L. H., et al. (2005) · AIDS · doi:10.1097/01.aids.0000196179.11293.fc · Cited by 67
A statistical model for HIV-1 sequence classification using the subtype analyser (STAR)
Myers, R. E., Gale, C. V., Harrison, A., Takeuchi, Y., & Kellam, P. (2005) · Computer applications in the biosciences · doi:10.1093/bioinformatics/bti569 · Cited by 43
Cited by
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
Hirsch, M. S., Günthard, H. F., Schapiro, J. M., Brun‐Vézinet, F., Clotet, B., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Mellors, J. W., Pillay, D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/589297 · Cited by 573
Cahn, P., Pozniak, A. L., Mingrone, H., Shuldyakov, A., Brites, C., Andrade-Villanueva, J. F., Richmond, G., Buendia, C. B., Fourie, J., Ramgopal, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61221-0 · Cited by 516
Machine Learning and Decision Support in Critical Care
Johnson, A. E. W., Ghassemi, M. M., Nemati, S., Niehaus, K. E., Clifton, D., & Clifford, G. D. (2016) · Proceedings of the IEEE · doi:10.1109/jproc.2015.2501978 · Cited by 432
Pineda-Peña, A.-C., Faria, N. R., Imbrechts, S., Libin, P., Abecasis, A. B., Deforche, K., Gómez-López, A., Camacho, R. J., de Oliveira, T., & Vandamme, A.-M. (2013) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.04.032 · Cited by 383
Metadata
- Authors
- Liu, T. F., & Shafer, R. W.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-06-01
- Volume
- 42
- Issue
- 11
- Pages
- 1608-1618
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2154164013
- Cited by
- 654
- References
- 19
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.